Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,008.50    0.00 (0.00%)
Bid:
1,000.00
Ask:
0.00
Spread: 11.50 (1.15%)
Market Cap: £4.93b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Trading Update

25 Sep 2019 07:00

RNS Number : 5383N
Babcock International Group PLC
25 September 2019
 

25 September 2019

Babcock International Group PLC (Babcock or the Group)

Babcock, the aerospace and defence company, is issuing the following trading update for the period from 1 April 2019.

Trading update

Trading across the Group is in line with our expectations.

 

Our Marine sector is performing well with increased activity across our UK warship support business and strong orders across our technology businesses. The Queen Elizabeth Class (QEC) programme is nearing completion with HMS Prince of Wales leaving Rosyth for sea trials while our Type 23 frigate life extension programme continues to progress. In Australia and Canada we continued to make good progress on our submarine and surface ship sustainment programmes. In Land, we are continuing to make good progress across our Defence Support Group (DSG) business and have successfully transitioned to the new CP6 contract in Rail. We have also seen an improvement in our South African business.

 

In Nuclear, activity levels have increased across defence though the civil nuclear market remains challenging. As expected, the Magnox contract transitioned to the Nuclear Decommissioning Authority at the end of August. In Aviation, we saw the successful start of our new international businesses in Canada and Norway and have made continued progress across our military businesses. While we have seen some delays in the award of new contracts in Aviation, overall bidding activity across the sector has increased.

 

Contract awards

The Group continued to win work across all sectors in the period, with win rates in line with our targets.

 

The highlight in the period was our selection as the preferred bidder for the Type 31 general-purpose frigate programme, which will provide the UK with a fleet of five new warships for £1.25 billion. The ships will be assembled at Babcock's Rosyth facility, and involve supply chains throughout the UK. Work will begin immediately following formal contract award later this financial year, with detailed design work to start now and manufacture commencing in 2021 and concluding in 2027.

 

Expectations for the year

We confirm our full year guidance for revenue, operating profit and free cash flow as set out in May 2019, including the phasing between the first and second halves of the year, especially for cash generation. We expect the first half to reflect the phasing of previously communicated step downs1, the normal seasonality of our business and last year's phasing of Fomedec equipment sales in our Aviation business.

 

Refinancing completed

During the period, both Standard & Poor's and DBRS confirmed the Group's credit rating of BBB following their annual credit reviews. We renewed our 5-year Revolving Credit Facility of up to £775 million and issued €550 million (c.£500 million) of 8-year bonds expiring in 2027.

 

As already announced, the estimated impact of this is to increase finance costs by around £5 million in FY20 and around £7 million in FY21 and reduce finance costs by around £2 million each year in the years following.

 

ends

 

 

For further information please contact:

Babcock International Group PLC

Simon McGough

Kate Hill

Director of Investor Relations

Group Director of Communications

Tel: +44 (0)20 3823 5592

Tel: +44 (0)20 7355 5312

FTI Consulting

Andrew Lorenz, Nick Hasell

Tel: +44 (0)20 3727 1340

 

 

Conference call

A conference call for analysts and investors will be held at 08:00 (UK time) this morning, hosted by Archie Bethel (Chief Executive) and Franco Martinelli (Group Finance Director).

 

Webcast link:

www.babcockinternational.com/investors/results-and-presentations 

 

Live call:

Standard International Access

+44 (0) 20 3003 2666

UK Toll Free

0808 109 0700

Replay (available for 7 days):

Standard International Access

+44 (0) 20 8196 1480

UK Toll Free

0800 633 8453

PIN

4072877#

 

A transcript will be made available at www.babcockinternational.com/investors.

 

 

Notes

1. As stated in May 2019:

a. Revenue step downs for the full year of £410 million (QEC £80 million, Magnox £256 million, exit and disposals £74 million). The first half impact is expected to be around £150 million.

b. Operating profit step downs for the full year of £63 million (QEC £2 million, Magnox £24 million, Holdfast £17 million, exits and disposals £10 million and Brexit-related Aviation restructuring costs of £10 million). The first half impact is expected to be around £35 million.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEMFALFUSEEU
Date   Source Headline
8th Jan 20213:23 pmRNSHolding(s) in Company
15th Dec 20207:00 amRNSBabcock appoints new Marine CEO
2nd Dec 20204:24 pmRNSDirector/PDMR Shareholding
25th Nov 20207:00 amRNSHalf-year results
10th Nov 20207:00 amRNSDirector appointment
28th Oct 20207:00 amRNSAppointment of Chief Corporate Affairs Officer
15th Oct 20209:38 amRNSHolding(s) in Company
13th Oct 20209:00 amRNSChief Innovation & Technology Officer Appointment
9th Oct 20209:00 amRNSType 31 briefing
6th Oct 202011:21 amRNSHolding(s) in Company
30th Sep 202012:47 pmRNSDirector/PDMR Shareholding
30th Sep 20207:00 amRNSBabcock appoints new Chief Financial Officer
21st Sep 20202:56 pmRNSDirector/PDMR Shareholding
15th Sep 202010:20 amRNSDirector/PDMR Shareholding
9th Sep 20208:00 amRNSPublication of Base Prospectus
25th Aug 20209:25 amRNSHolding(s) in Company
18th Aug 20209:44 amRNSHolding(s) in Company
17th Aug 20209:11 amRNSDirector/PDMR Shareholding
14th Aug 20203:40 pmRNSDirector/PDMR Shareholding
14th Aug 20203:39 pmRNSDirector/PDMR Shareholding
4th Aug 20201:39 pmRNSDirector/PDMR Shareholding
4th Aug 202011:33 amRNSResult of AGM
4th Aug 202011:01 amRNSDirector/PDMR Shareholding
4th Aug 20207:00 amRNSTrading update
31st Jul 20207:00 amRNSDirectorate Change
16th Jul 20209:07 amRNSDirector/PDMR Shareholding
16th Jul 20209:05 amRNSDirector/PDMR Shareholding
16th Jul 20209:05 amRNSDirector/PDMR Shareholding
7th Jul 202011:04 amRNSHolding(s) in Company
7th Jul 202011:02 amRNSHolding(s) in Company
1st Jul 20204:50 pmRNSNotice of AGM
1st Jul 202010:26 amRNSDirector/PDMR Shareholding
1st Jul 20207:00 amRNSBabcock appoints new Chief Executive
11th Jun 20203:52 pmRNSDirector/PDMR Shareholding
11th Jun 20207:00 amRNSFinal Results
19th May 20207:00 amRNSItalian Anti-Trust Authority decision
11th May 20207:00 amRNSRevised date for full year results and AGM
20th Apr 20207:00 amRNSDirector appointment
6th Apr 20207:00 amRNSUpdate on Coronavirus (COVID-19)
19th Mar 20202:47 pmRNSDirector/PDMR Shareholding
6th Mar 20209:43 amRNSSale of Context
14th Feb 202011:23 amRNSHolding(s) in Company
12th Feb 202010:33 amRNSDirector/PDMR Shareholding
12th Feb 20207:00 amRNSTrading Update
5th Feb 20207:00 amRNSDirectorate Changes
20th Jan 20201:52 pmRNSDirector/PDMR Shareholding
16th Jan 20209:13 amRNSDirector Declaration
25th Nov 201912:41 pmRNSContract for Australian Future Submarine programme
20th Nov 201910:55 amRNSDirector/PDMR Shareholding
20th Nov 20197:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.